Abstract
The verrucous epidermal nevus (VEN) is the most common type of epidermal nevi. As lesions can be disfiguring, treatment is often sought. Many therapeutic approaches have been reported, with variable efficacy and safety. Picosecond (PS) lasers are novel laser devices designated to target small chromophores. A side effect of these lasers is blistering due to epidermal-dermal separation. We aimed to harness this side effect of the PS lasers to treat patients with VEN. The purpose of this study was to report our experience treating VEN using a PS 532-nm laser. We present a retrospective case series of six patients with large VEN who were treated using a PS 532-nm laser (2–6 treatments, 8–10 weeks apart). Response in clinical photographs was assessed by two independent dermatologists and graded on a scale of 0 (exacerbation) to 4 (76–100% improvement). Patient satisfaction was recorded on a scale of 1–5. All patients demonstrated significant improvement. Average improvement was 3.7 on the quartile scale of improvement. Patient satisfaction rate averaged 4.7. The PS 532-nm laser is a promising novel modality for the treatment of large VEN.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10103-017-2427-z/MediaObjects/10103_2017_2427_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10103-017-2427-z/MediaObjects/10103_2017_2427_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10103-017-2427-z/MediaObjects/10103_2017_2427_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10103-017-2427-z/MediaObjects/10103_2017_2427_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10103-017-2427-z/MediaObjects/10103_2017_2427_Fig5_HTML.jpg)
Similar content being viewed by others
References
Sugarman JL (2007) Epidermal nevus syndromes. Semin Cutan Med Surg 26:221–230
Ruggieri M, Praticò AD (2015) Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 22(4):207–233
Igawa S, Honma M, Minami-Hori M, Tsuchida E, Iizuka H, Ishida-Yamamoto A (2016) Novel postzygotic KRAS mutation in a Japanese case of epidermal nevus syndrome presenting with two distinct clinical features, keratinocytic epidermal nevi and sebaceous nevi. J Dermatol 43:103–104
Miranda LQ, Fracaroli TS, Fonseca JC, Fontenelle E, Curvo RP, Porto LC, Souto R (2013) Analysis of mutations in the PIK3CA and FGFR3 genes in verrucous epidermal nevus. An Bras Dermatol 88(6 Suppl 1):36–38
Brandling-Bennett HA, Morel KD (2010) Epidermal nevi. Pediatr Clin N Am 57:1177–1198
Lee BJ, Mancini AJ, Renucci J, Paller AS, Bauer BS (2001) Full-thickness surgical excision for the treatment of inflammatory linear verrucous epidermal nevus. Ann Plast Surg 47(3):285–292
Toyozawa S, Yamamoto Y, Kaminaka C, Kishioka A, Yonei N, Furukawa F (2010) Successful treatment with trichloroacetic acid peeling for inflammatory linear verrucous epidermal nevus. J Dermatol 37:384–386
Mutasim DF (2006) Successful treatment of inflammatory linear verrucous epidermal nevus with tacrolimus and fluocinonide. J Cutan Med Surg 10:45–47
Kim JJ, Chang MW, Shwayder T (2000) Topical tretinoin and 5-fluorouracil in the treatment of linear verrucous epidermal nevus. J Am Acad Dermatol 43:129–132
Boyce S, Alster TS (2002) CO2 laser treatment of epidermal nevi: long-term success. Dermatol Surg 28:611
Hohenleutner U, Landthaler M (1993) Laser therapy of verrucous epidermal naevi. Clin Exp Dermatol 18:124–127
Osman MA, Kassab AN (2016) Carbon dioxide laser versus erbium:YAG laser in treatment of epidermal verrucous nevus: a comparative randomized clinical study. J Dermatolog Treat 13:1–6
Hammami Ghorbel H, Lacour JP, Passeron T (2014) Treatment of inflammatory linear verrucous epidermal nevus with 2940 nm erbium fractional laser. J Eur Acad Dermatol Venereol 28(6):824–825
Panagiotopoulos A et al (2009) Assessment of cryotherapy for the treatment of verrucous epidermal naevi. Acta Derm Venereol 89:292
Lapidoth M, Israeli H, Ben Amitai D, Halachmi S (2013) Treatment of verrucous epidermal nevus: experience with 71 cases. Dermatology 226:342–346
Reiter O, Atzmony L, Akerman L, Levi A, Kershenovich R, Lapidoth M, Mimouni D (2016) Picosecond lasers for tattoo removal: a systematic review. Lasers Med Sci 31:1397–1405
Ho SG, Goh CL (2015) Laser tattoo removal: a clinical update. J Cutan Aesthet Surg 8:9–15
Fox BJ, Lapins NA (1983) Comparison of treatment modalities for epidermal nevus: a case report and review. J Dermatol Surg Oncol 9:879–885
Alam M, Arndt KA (2002) A method for pulse carbon dioxide laser treatment of epidermal nevi. J Am Acad Dermatol 46:554–556
Forbat E, Al-Niaimi F (2016) The use of picosecond lasers beyond tattoos. J Cosmet Laser Ther 18:345–347
Alonso-Castro L, Boixeda P, Reig I, de Daniel-Rodríguez C, Fleta-Asín B, Jaén-Olasolo P (2012) Carbon dioxide laser treatment of epidermal nevi: response and long-term follow-up. Actas Dermosifiliogr 10310:910–918
Michel JL, Has C, Has V (2001) Resurfacing CO2 laser treatment of linear verrucous epidermal nevus. Eur J Dermatol 11(5):436–439
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Levi, A., Amitai, D.B., Mimouni, D. et al. Picosecond 532-nm neodymium-doped yttrium aluminum garnet laser—a promising modality for the management of verrucous epidermal nevi. Lasers Med Sci 33, 597–601 (2018). https://doi.org/10.1007/s10103-017-2427-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-017-2427-z